Related Experiment Video
Updated: Jun 8, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle
Monica L Hulbert1, Robert C McKinstry, JoAnne L Lacey
1Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA.
Insights
Children with sickle cell disease (SCD) and strokes often experience new infarcts despite blood transfusions. This study found that silent cerebral infarcts are common in these children, highlighting the need for better stroke prevention strategies.
Area of Science:
- Pediatric Neurology
- Hematology
- Vascular Medicine
Background:
- Children with sickle cell disease (SCD) and prior strokes receive transfusions for secondary stroke prevention.
- Despite transfusions, about 20% experience a second overt stroke.
- Silent cerebral infarcts are clinically significant in children with SCD.
Purpose of the Study:
- To test the hypothesis that silent cerebral infarcts occur in children with SCD receiving transfusions for secondary stroke prevention.
- To investigate the incidence of new cerebral infarcts (overt or silent) in this high-risk pediatric population.
Main Methods:
- Prospective cohort study of 40 children with SCD and prior strokes at 7 academic centers.
- Regularly scheduled brain MRI and MRA approximately every 1-2 years.
- Studies reviewed by a panel of neuroradiologists; eligibility required regular blood transfusion therapy.
Main Results:
- Progressive cerebral infarcts occurred in 45% (18 of 40) of children during chronic transfusion therapy.
- Seven children had second overt strokes, and 11 had new silent cerebral infarcts.
- Worsening cerebral vasculopathy was significantly associated with new cerebral infarction (RR = 12.7, P = .001).
Conclusions:
- Children with SCD and strokes receiving regular blood transfusions experience silent cerebral infarcts at a higher rate than previously recognized.
- New cerebral infarcts, both overt and silent, are common despite current secondary stroke prevention strategies.
- Additional therapeutic strategies are urgently needed for secondary stroke prevention in children with SCD.
Abstract:
Children with sickle cell disease (SCD) and strokes receive blood transfusion therapy for secondary stroke prevention; despite this, approximately 20% experience second overt strokes. Given this rate of second overt strokes and the clinical significance of silent cerebral infarcts, we tested the hypothesis that silent cerebral infarcts occur among children with SCD being transfused for secondary stroke prevention. A prospective cohort enrolled children with SCD and overt strokes at 7 academic centers. Magnetic resonance imaging and magnetic resonance angiography of the brain were scheduled approximately every 1 to 2 years; studies were reviewed by a panel of neuroradiologists. Eligibility criteria included regularly scheduled blood transfusion therapy. Forty children were included; mean pretransfusion hemoglobin S concentration was 29%. Progressive cerebral infarcts occurred in 45% (18 of 40 children) while receiving chronic blood transfusion therapy; 7 had second overt strokes and 11 had new silent cerebral infarcts. Worsening cerebral vasculopathy was associated with new cerebral infarction (overt or silent; relative risk = 12.7; 95% confidence interval, 2.65-60.5, P = .001). Children with SCD and overt strokes receiving regular blood transfusion therapy experience silent cerebral infarcts at a higher rate than previously recognized. Additional therapies are needed for secondary stroke prevention in children with SCD.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Transient Ischemic Attack l: Introduction
Hemorrhagic Stroke l: Introduction
Stroke: Introduction and Types
